BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus

A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes

NCT06938334 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes

NCT02325206 ·Status: COMPLETED ·Phase: PHASE1

A Study of CT-868 in Type 1 Diabetes Mellitus

NCT06062069 ·Status: COMPLETED ·Phase: PHASE2

Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)

NCT04234867 ·Status: TERMINATED ·Phase: PHASE1

STOP-T1D Low-Dose (ATG)

NCT04291703 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes

NCT00071409 ·Status: COMPLETED ·Phase: PHASE2

Denosumab for Type 1 Diabetes

NCT06524960 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes

NCT02020616 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

NCT07088068 ·Status: RECRUITING ·Phase: PHASE3

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

NCT04628481 ·Status: TERMINATED ·Phase: PHASE2

PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)

NCT00690066 ·Status: COMPLETED ·Phase: PHASE2

Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

NCT00998699 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

NCT07282054 ·Status: COMPLETED ·Phase: PHASE3

Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus

NCT01236404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM

NCT03688711 ·Status: COMPLETED ·Phase: PHASE3

Study of LY2409021 in Participants With Type 1 Diabetes

NCT01640834 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM

NCT03907202 ·Status: TERMINATED ·Phase: PHASE1

Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)

NCT03794973 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)

NCT03713684 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

NCT02691247 ·Status: COMPLETED ·Phase: PHASE2

Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

NCT02715193 ·Status: COMPLETED ·Phase: PHASE1

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

NCT06783309 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

NCT07142252 ·Status: RECRUITING ·Phase: PHASE2

A Study for Participants With Type 2 Diabetes Mellitus

NCT00871572 ·Status: COMPLETED ·Phase: PHASE2

Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes

NCT00427154 ·Status: TERMINATED ·Phase: PHASE3